Novel biogenic silver nanoparticles produced by <i>Enterobacter xiangfangensis</i> Pb204 reinstate the activity of specific antibiotics against resistant ESKAPE pathogens.

ABSTRACT: Antimicrobial resistance (AMR) in pathogenic bacteria remains a major challenge and critical threat to the global healthcare industry, demanding alternative therapeutic strategies. Among the various nanomaterials studied, silver nanoparticles (Ag-NPs) have shown promising antibacterial properties due to their broad-spectrum activity, oligodynamic effect, and reduced possibility of inducing microbial resistance. This study investigates the antimicrobial efficacy of biogenically synthesised silver nanoparticles using a cell-free extract of Enterobacter xiangfangensis Pb204 combined with antibiotics against eight pathogenic bacterial strains, including ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii</

SUBMITTER: Sathish Sundar P 

PROVIDER: S-EPMC12703627 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature